Saturday - September 20, 2025
Anti-Cancer Drugs Journal Issues Research Articles in September 2022 Edition
September 01, 2022
LONDON, England, Sept. 1 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its September 2022 edition:

Original Studies:

* MiR-4284 inhibits sensitivity to paclitaxel in human ovarian carcinoma SKOV3ip1 a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products